{"ticker": {"uuid": "b57d75b8-878f-4d4f-a4e4-c933f3f16f1f", "symbol": "BGLC", "name": "BioNexus Gene Lab Corp Common stock", "exchange": "NASDAQ", "country": "US", "sector": "Basic Materials", "industry": "Specialty Chemicals"}, "articles": [{"title": "Brenntag stock holds steady as the chemicals distributor focuses on earnings and portfolio strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOOVhMMGVaUU1WSnBwcktjRkdVWEJOMGp2Vm9aUlFNMGlHTTlQeUk1VnIwVWo5cEJTOHZxSm5oUF9hcjc4clFYTFhyRWxLQlh3a3ZxMEtGbHRiQXFmX2FGTkhIMV9fcW5ScDN2b2s2R0p2SFRrVVFaR3ktYnAtdjFnOE13VnZiQTNEOU5xRngzSWpscmxoSy1peHpzMTVCMDFxWEJOQ3NGbGdWa0NhandNbmROWW50SVl1VDJRdmY0WkUyY2d4?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T19:07:13+00:00", "published_display": "15 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Nucor (NUE) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPWmxCZnlHNXQ3eWE1NkVVWTFMZEI4ai1oN1NQWmJoQ0VXUWtpQllBMmVNbmZ6eFl6OExTREVVM0JQejVOZ2Nqb3dDX2tEQ3AtNEE1T1IzX2VNS3RiZXRjSm1wNUxsYVBDVjZLSURiZHJITm1TWWdnQ0Zpdm8ybXVtcmxfRFdyb2c?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:40:03+00:00", "published_display": "15 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Croda stock reflects specialty chemicals strategy amid evolving global demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRnpyWDh4eXJkRDhXZ3dSSWRkNDRpeFlBZENqZllwZWZkVzVHcnAxQVFqSnZ5dTBuQzJHMXU1Y3l5OTBjY2Jfd0JNS05VVHZhYnhZUGlnNjA3SG5LeGR6eklOdFdwOHpvUTVpblItcGJfbklfRzZURTBFam44a1k5c3RZbm40LUE0OVVJbTZRR2xSMXNidTVRbmtkajlZRmRkOTdkLVZ6TlF2Szl6SjNvTWdLNENSSmE3LU5QeVZ6YlNpV1hER0k3RA?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T10:24:50+00:00", "published_display": "15 Jul 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kemira stock reflects steady water treatment demand as specialty chemicals strategy evolves", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZjlGazNUT1JsWElvMWdxbVZ1SU81UkhtVktQWnFDTTFrSzNiMDU2OU1abl81ZkYxZ0N1OUZReTR5Y0NsR19tWHpWQVRNTDdidkNyc2pGMXRWQld0aHU5bnE0aDk2VzM2Zkw0VFFBUV9oc2YyYUdZM09KM1BBaUpab19hOXB1MkticUJFYno5dDE3R05rdmR4Nm9UbVpVSzQ2NER2Skc2eldwakxpUUpJZHFObkR5NU1PUUVCTmFEeF9ZX09lTW0wc1prankxQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T08:04:23+00:00", "published_display": "11 Jul 2026 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evonik stock holds steady as specialty chemicals strategy targets higher-margin growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNRXhUTWdEZHNCbjJiR0phSGswLWs0T0ZCajRmSUNZdE5Td2hjbGFHVl9HZjhBU0dvaFNyWGxGbnZteWtLN3ZQZkctU0RQLTNybTFXam5CdlB1NEh1QWRFWjJkeEFlakp5aTZqVnRYRGdiQlJFN0E3NDFFcThiTmhPbURXTmRsaF9UX2NaaFlRSkFxOERCR2ZsWHNpdGdJZmxlbXNCSlB5Y0tjT2JwMnhHRjVEekhQZmVuTVFGaEN0dnExUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T11:52:51+00:00", "published_display": "10 Jul 2026 11:52", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dow stock holds steady as chemicals demand shapes earnings outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOcGpkQk9DeEI3blpxc0RSeTh2UVhkYV8xbjYyd21IUlZDQ2ZLVW1NcW1DTk9ESXlHRHYtb2J2X29oRmdTYVROTjBXWU9QMlpSeENXT2xHMXV3S2xtRWQ1Tzd6WjBuc1FoZmR6SWRkSXpRQldIOUE2a0ZUV3oxcnkyRXR3Nmk2YWdnRG1QQWhKeFBZaUs4ZnFFM3MxNElnRmZJYmx0eGpJWGFPUnUyUFJJUWc0eXptOEQyQjBKeUlsTzZxdkE?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T11:09:56+00:00", "published_display": "10 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ESI stock stays supported by specialty chemicals exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRFdBa1k2YzYxY2tPMW9lQjZtSzVRUEZJdmNwVHUtM2NGdVlSQ0JPeUpCUXNfc2pINmRWMTBBYTRCZEJiZ0RJdk9RWVRvRFVQY3h6WGNqdEFfNWFsWEtMSmN5ZzBzNGhjcnVudEtuX0s2WnNNQ2M2aWx0YkNxV2NxSk56bGFVb2pEckpUMW1qVGQ3emItYTBtd3pOV0VVQTRYdDdDVGlaUFlPSHFkYUJZaHJQYzlJdVU?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T18:07:25+00:00", "published_display": "09 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADEKA stock stays supported by specialty chemicals demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQVW9MNGVDYWh4czVqV25mRjh4dDc0OTByZWdBX0NRTkpIOEJHOHcyTkw2d0dBSDd6VmM5RUdaaHVsZjZWMFJLLUMwRVZOTkdGaFFIcTB2Qk00RnhqX1NSYnVRd2lFckFEeGlTZnVKRXpUZnFDSVhhZzQxT0NXSmdUeTlhRURZZ3A3ZXRQeDJneGdBbmMtVG5HSHlRMHZ6TG5LcWhiRy14RHgzWFZOSDBwNEk5RGtvUWM?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T14:29:24+00:00", "published_display": "09 Jul 2026 14:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is LyondellBasell Industries (LYB) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRVFBOXJPUmFJN0taTHZPaWo0LUxGNjVaWlM0TzJTWkkyWm5DT09xdnk4X3lXM3pPMzViMXJ1cy1GcGFfbzNYNmxKWThwX2gtRDZqM3o4RTEyODlSeWU4MDExMWM3S0RtQUh2bmlWT01qakhodWp2X0V4bURMOUF0SUpjRmNBX3VKSVcteFdaMXRnQlRZLVR1UFRvOWM1cDdDRHhobGwwMkdOeFl4QURZ?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "The article focuses on the enterprise value to revenue forward metric for BioNexus Gene Lab Corp (NASDAQ: BGLC). It presents the stock's financial overview on TradingView, indicating that the market was closed with no trades at the time of publication. The content is primarily a ", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:39:45", "published_display": "28 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celanese sets August earnings date, analysts see cautious stock outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZVJ2MXpSM0FaLVVBTXg2c1Q3elJYdnR0UWowYVoxbERhUHZab0JmQlpiU0tZbHR0SFZiSlNvemIxcEM2VUVGVWZvNi11UHRxdzdKeHJEQ2V3WU4ydHh3a3hLWjljUHY4U29mZXYxU0FROFdpLTFMSDF1bzBQcGg5RW83bWxjRXF5dGVRWEZJcE5rRHFnbWtGZDlxQUlrZF9mOEp6RzJod1hqbFd5d2pTUFEzdkJET1hxLVRnTllHYlpKT2dFdkd3Tg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial information for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication and no trades had occurred. The data is presented within the contex", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T03:09:49", "published_display": "28 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Company Profile & Introduction", "summary": "The article provides a company profile and introduction for BioNexus Gene Lab. It offers basic information about the company.", "url": "https://www.moomoo.com/stock/BGLC-US/company?chain_id=Name1K9-3FXPhg.1l0sio0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A39,%22f%22%3A%22www.moomoo.com%2Fus%2Flearn%2Fdetail-berkshire-bites-into-domino-s-what-lies-ahead-110592-241111183%22%7D", "source_name": "Moomoo", "published_at": "2026-06-27T22:40:49", "published_display": "27 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its \"Price to book forward\" metric. It states the period value and change percentages for this financial indicator. The content is presented within the context of a TradingVie", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T21:39:27", "published_display": "27 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its Enterprise Value to EBITDA forward. The data is presented within the context of a TradingView financial analysis page, detailing market information for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:41:15", "published_display": "27 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Croda International outlook under scrutiny, analysts track specialty chemicals stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVjZqUzJBQjhDb1dPMlpoY0hsclY0bTlQdWhjV1pfQ2RVZDhjTzQ4U3lXNnBUUHR2ZzBYd294TDBiNV9tYzA3dngtNzQyRE52ekl1c1ZCNVlETGd6S05ycFY1Ukw5dTdTcHg2Q0YxSGpDMnFYS2s3eVhLMEZIaE1iTE1xYjMya0xzempoTFY5NGRlX3MwR0c5aDV1MlBJclRKeHdOVjhiWHVwMnBIZTlXUUpWSTkyQXd0cm84cDgwYVpmOGJn?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-27T07:04:59+00:00", "published_display": "27 Jun 2026 07:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (BGLC) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwJBVV95cUxQdS1lVFZhY0NBX1MtazlON2VaQWVhcXh4Z3B5OWxJOVdnZFo4Sk1DdmpNdU04TFJHaktHOE5XNWE0clR4RE9GMW1GdXpaNGJFaGt6b2x5UHRmV19Id0h5YzVfemxVYzA0YWMydFVnSjlZNGNWWDlCWXVlLXQ1Q1AwTEdrVTNpWFZZaFBVMjBrYl9pMzU5azhBM1ZtWEhpbThwc3VlblhCeURDS0ZfYzE1WGIxNVdYdTVfZWxfNndhcHlCWGJuU2NjUGk3TUY5VFIwM2RqTnpmbEc5eGRVaDg2WEFLQThFcVlkSFh3bE51YThfTWMzTUJJajMtdE1OS1lYQXlUQlc4d1ZjQ0J1ZV9NUHh1VGs1SmM0LU5pcDVjVk5zOGpBWXBrbTdQSFhLUEY2bXR5VmxRWmhQMnc?oc=5", "source_name": "Moomoo", "published_at": "2026-06-24T09:43:00+00:00", "published_display": "24 Jun 2026 09:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of BioNexus Gene Lab Corp (BGLC)'s dividend history and stock split events. It states that no dividends have been distributed in the past five years and lists one upcoming merger stock split event with a 10->1 ratio scheduled for April 3, 2025.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:50", "published_display": "18 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses the revenue breakdown for BioNexus Gene Lab Corp (BGLC), noting that relevant data regarding business segments and regional revenue and profit contribution have not yet been disclosed by the company. It highlights the current stock price and market capitaliz", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T08:39:50", "published_display": "18 Jun 2026 08:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of BioNexus Gene Lab Corp (BGLC), highlighting its current valuation score of 8.38 within the Biotechnology & Medical Research industry. It notes the company's P/E ratio of -1.76 and indicates that key P/B, P/S, and P/CF data have not ye", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T04:10:45", "published_display": "18 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Institutional Confidence", "summary": "This article from TradingKey provides an overview of institutional confidence in BioNexus Gene Lab Corp (BGLC), including its stock price, market cap, and various TradingKey Stock Scores. It details institutional shareholdings and recent changes in holdings by key investors. The ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:50", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for BioNexus Gene Lab Corp (BGLC), indicating that no earnings forecast score is currently available for the company. It notes that the Biotechnology & Medical Research industry average is 8.13 and states that relevant data for financial", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:05", "published_display": "18 Jun 2026 02:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus urges Malaysia-China biotech cooperation to evolve from trade to co-development and regional healthcare integration.", "summary": "BioNexus Gene Lab Corp. calls for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on co-development, clinical validation, and commercialization. CEO Sam Tan emphasized Malaysia's strategic position as an ASEAN hub to facilitate", "url": "https://pluang.com/en/news-feed/bionexus-gene-lab-corp-ajukan-kerjasama-bioteknologi-malaysia-china-lebih-dari", "source_name": "Pluang", "published_at": "2026-06-09T23:44:04", "published_display": "09 Jun 2026 23:44", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Urges Malaysia\u2013China Co-Development of Biotech Platforms After Kuala Lumpur Forum", "summary": "BioNexus Gene Lab is advocating for increased biotechnology co-development between Malaysia and China, alongside the establishment of regional precision healthcare platforms. The company highlighted its proposals at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, focu", "url": "https://www.tradingview.com/news/tradingview:57b4dadcf3049:0-bionexus-gene-lab-urges-malaysia-china-co-development-of-biotech-platforms-after-kuala-lumpur-forum/", "source_name": "TradingView", "published_at": "2026-06-05T12:39:32", "published_display": "05 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia\u2013China biotech co-development model", "summary": "BioNexus Gene Lab Corp. (Nasdaq: BGLC) is advocating for a shift in Malaysia\u2013China biotechnology collaboration from simple trade to deeper co-development, clinical validation, and regional commercialization. The company suggests Malaysia can serve as an ASEAN \"execution hub\" for ", "url": "https://www.stocktitan.net/sec-filings/BGLC/8-k-bio-nexus-gene-lab-corp-reports-material-event-32f4157ff1dd.html", "source_name": "Stock Titan", "published_at": "2026-06-05T12:39:32", "published_display": "05 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC - BioNexus Gene Lab Corp Stock Price and Quote", "summary": "This article provides a detailed stock quote and financial overview for BioNexus Gene Lab Corp (BGLC), including its recent stock performance, key financial metrics, and executive information. It also lists recent news announcements detailing the company's strategic partnerships,", "url": "https://finviz.com/stock?t=BGLC", "source_name": "Finviz", "published_at": "2026-06-02T21:40:52", "published_display": "02 Jun 2026 21:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 2.37% as Stock Tests Key Support Area - Ascending Triangle", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPZnF3d1RYQzJDRWtGSjVOQjNicXlrT0Z0empuaExpblNPcXVMNThpQVU4RGRVT0NDQ0xGUmtvX0xSekpidHpMRnhRS19qYl96RzNHRzlNQ3lFcEdpQlYyMlhheWNFX3BNWldSN284MjEwRmt6UjRvNVl6SXE0LXlZX0stazcwQlgxQ0RoalVwS1pkdnpFaHVjY1NmWUlna2ZESmpoalliWFBvekk2MmFOcjZlc3dHNEE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development", "summary": "BioNexus Gene Lab Corp. is advocating for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on joint development initiatives. The company believes this shift, involving shared research, technology transfer, and co-creation of sol", "url": "https://www.geneonline.com/bionexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-collaboration-focused-on-joint-development/", "source_name": "GeneOnline", "published_at": "2026-05-31T11:09:54", "published_display": "31 May 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia\u2013China Biotechnology Cooperation to Move Beyond Trade into Co-Development", "summary": "BioNexus Gene Lab Corp. emphasized the need for Malaysia and China to deepen their biotechnology cooperation beyond trade into co-development, clinical validation, and commercialization. Speaking at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, BioNexus CEO Sam Tan ", "url": "https://norfolkdailynews.com/online_features/press_releases/bionexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-cooperation-to-move-beyond-trade-into/article_bfee0d2e-0087-5c69-a5f2-abea6b14470c.html", "source_name": "The Norfolk Daily News", "published_at": "2026-05-29T13:10:00", "published_display": "29 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Turning Malaysia into a bridge for China\u2019s biotech ambitions", "summary": "BioNexus Gene Lab (Nasdaq: BGLC) advocated for deeper Malaysia-China biotechnology cooperation at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, moving beyond trade to co-development. CEO Sam Tan proposed Malaysia as an ASEAN execution hub for precision diagnostics, ", "url": "https://www.stocktitan.net/news/BGLC/bio-nexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-3vcsetm0qrdk.html", "source_name": "Stock Titan", "published_at": "2026-05-29T13:08:52", "published_display": "29 May 2026 13:08", "sentiment": "positive", "sentiment_pct": 78, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia\u2013China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxOdG1WQ05FMnltWlFfbDhGNHpuXzN0WUJaNmdNWk1rQjFWc1pvM2J0dUNmbUh5azVyUllrQkxmTHBWVzhaa3Y4UTdWV3ZqZ0cxa2pLSDdvc1hJYXJCOVBmOXRNdjdwZW1ta2xrUVh6Q005U1c1Zk5wZmdsOS1sVkxPUHV1LU9EV2VjR3NWVVpNRWhwR0FYMGRFcFRUVWFJOFdjNjVYVWEwZTZmai00Q2xqTnRBZExySkxBcUJOTmQtRHpuRFdxclN1OW1MZ19MbTVlLVAtY015bVRwQzF3QVBZa2oyOG9LVFFBSWRGTDB6WHUyemlVNUNoejhqUU04d3UzRzVKY0d3WWI0LWVpUnN2YkJkd00?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears \u2013 Key Levels to Watch - Gap and Reverse", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPdkJxNnVZdFp3ZENmY3F5VktiRXdBZXRzUEhzZlROUE5MNUV3elFWdGVfSDFfS0RtdXhqRG5DVWJPT3RFNklSNjBaTE10WkktYmFnVkJOYnZ2VnRJWFptaUFtc3JDZ1R6dUtYWG1WS0FZeFpRdWVBVXZWQzZ6Ukk5VndqYkJ0cTB2U1JPM2s3SzZEVFV1b0dQeDh6R0JPQ3N6TE0xeFNYaDNXc2NiS0lHVjhqbkZDb2kxQnZPZUdTc205TmI1MlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 3.33% as Stock Tests Key Support at $2.20 - Fibonacci Arc", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOU2JyWW5Ya29telctZEZrUnNTS2hHLUhkZXRpUHRVQmhNM0xwM05faFljWlRoSzZDWmV5MHE0eFo4Y0dYX0RPNUlFUlo4OFlkT1pmZ09EZUFVSmFyTzQxYWdNM203MGpOTkN1eF9xOS0td3B2NlVnQTVwQXlBdmpYTTZFZjhLazdxdDNiMFBOSVFaaDhjUkVGakZIQmxMUDEzVUVmY01rYzBELWhudERHQTl2RTFYQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under Scrutiny - Mid Cap Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQYXdXOHpIM2NGaUs4OEt3eXRJUWcxMTBKT2dFZVNzVEdYem1vY3drd2dJU0k2VGxXTlNseHRJZmNpbDNUZ2E1dER5T0JCVkk0RGxiR21pYTRldFF4N0RvTkFjaDBTLWI2XzdiaHk4T1VkT2xzOGhiYzFueXUzMU1Rb1QyNDkzbnhEeURoWHJmM0RVeldHZzZvOTl5MGE5U2stS04wbHV6aDZqLThIUHBXcDZ1RGJRd0VVTlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 3.33% as Stock Tests Key Support at $2.20 - Long Term Entry Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPOC1mYnNkSnBKQmFGQUlDVVU4RndTNHZqMlpJcFFpYmVILVZRV05uUzVHdl9aa3RUSzJIbjR1a0xocm5VeU4yTmFNYS1zNzZUV2YxTFh3anBfVmt4ZVV5ZWdCLTcxaEJlV3BTSXFFdU91WWlMd1hXaWFXTkM1R2FvSVZaY3ZOSEZaWmhYSkVCenFIQ2hKLUMzejRKb2ZrUE5IenBBYjg3eGtUT2FkaFVhNg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under Scrutiny - VWAP Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPSW0ydmdtZm9xMnBDTHhlRHpyZ0tLUXdJUGo3YmNVSm9RX2JsaURZZks5WmFyMGlGaExrTE5CREMtNEtUaW5iYy1zSGh3NmZKdkhzWjdjRlZiMGRad3pycUQwLUliaE9oYklxR21IMFN1dXNhYU51N0poNVhVUVBnTEJjN3dPdzg4OVY3NVNsUVJlN3VMSld2YUQyWjc3RUMyUk82NW1DYTIyejMtTUI5OA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key Support - OBV Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNOTlLcVJobmxEYVhUQURodXptaXhpLUdSNWFMQ09hdnB6NE5fTFZzRWxDcVU3OUI1cHQ4T0FNd0RFSXJYYWJSSG5lOWNnRi0tV0RfaENrRXZJcjZKQnp3RS1hQmI5dGtuU0c3U3VuOFRQbVFJa3Q0VXpROFlyTTFSMTZPdDhmRjlkN21sTWtLX29hZzR2ejJDbHJaUElTS29JbGR3RE95V3FnbHBuSGdtV2N3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Industrials Stocks Moving In Wednesday's After-Market Session", "summary": "This article lists 12 industrial stocks that experienced significant movement in Wednesday's after-market session, categorizing them as gainers and losers. Companies like Linkers Industries and Heico saw increases due to factors such as earnings reports, while BioNexus Gene Lab a", "url": "https://www.sahmcapital.com/news/content/12-industrials-stocks-moving-in-wednesdays-after-market-session-2026-05-28", "source_name": "Sahm", "published_at": "2026-05-27T19:40:27", "published_display": "27 May 2026 19:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) \u2014 10-Q Summary", "summary": "BioNexus Gene Lab Corp (BGLC) reported its first-quarter 2026 results, showing a significant decline in revenue to $22.84K, a 98.9% decrease year-over-year, while reducing its net loss per share to ($0.23), a 35.2% improvement. The company is actively pivoting its business strate", "url": "https://www.tradingview.com/news/tradingview:73dd3d8d0eb9e:0-bionexus-gene-lab-corp-1q-2026-revenue-22-84k-eps-0-23-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-15T21:10:00", "published_display": "15 May 2026 21:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp BGLC", "summary": "This page provides an overview of BioNexus Gene Lab Corp (BGLC) stock performance, showing a closing price of $2.015, a decrease of 2.18%. It includes current market data, a market capitalization of $4.87M, and sections for financials, discussions, and analysis. The platform also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/comments", "source_name": "TradingKey", "published_at": "2026-05-12T19:09:40", "published_display": "12 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (Nasdaq:BGLC) - Stock Analysis", "summary": "BioNexus Gene Lab (Nasdaq:BGLC) is analyzed with a market cap of US$5.2m. The company's stock has shown significant declines over multiple periods, including a 99.07% drop over five years, and analysts are not currently covering it. There are substantial risks highlighted, such a", "url": "https://simplywall.st/stocks/us/capital-goods/nasdaq-bglc/bionexus-gene-lab", "source_name": "Simply Wall Street", "published_at": "2026-04-27T06:38:42", "published_display": "27 Apr 2026 06:38", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPLUlYQWNGazVwdFFaY3Z2Qmk2blZCYWtQN2c2bTZyNFhKbm0zLTJlanpnUUwxckk3Y09LOG1RN2ZwZ056emo2NUdNRGFqQWN5SS1vUnMwcFR4Q1BKVElPdm44QTNGUXpUYzhVeEhQSkhISDlKS0lBRWJMZURjRFZ5NmdtMGE2aXM1ZTJYN1djNkZiZHJrNmpjYkpTd2N4SDhOeEs4MTd1bnZHcVFEMzUzT0VBX2VfanZnRlVJVnhJVVZUY0FHZkFpbnF2VUV0ZTJwNGw2YVA3a3YzcHVHcVJuNWJOcDdZQQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61)", "summary": "BioNexus Gene Lab reported fiscal-year revenue of $7.42 million, a 21.9% decline due to lower Chemrex volume and foreign exchange. The company also posted a net loss per share of $(1.607) and an 88% increase in operating loss year-over-year. Despite the revenue decline, gross mar", "url": "https://www.tradingview.com/news/tradingview:2679d30d35f27:0-bionexus-gene-lab-10-k-revenue-7-42m-eps-1-61/", "source_name": "TradingView \u2014 Track All Markets", "published_at": "2026-04-14T21:39:50", "published_display": "14 Apr 2026 21:39", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Aris Mining Corporation (ARIS) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmFpNU9NQ2JPcVZjV241emlTU1BXRHY5dDE4dFktLTNlaldOZnFpZ0xWNm8ySkFnbVZlaVpBRlFDQjVuWGQxc09NZ2ZQRGo5T25pWXN3UWthcVZsbHNnV21VU3V6WEM0ZWVmTE9oZW91VFFBcW5EcVFneUNyLXpCZmdDamxBQlJxeXZ2QXZ1aGg1Y2ZfSkZkVE0zUlZaYUE?oc=5", "source_name": "qz.com", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC Stock Price, Quote & Chart | BIONEXUS GENE LAB CORP (NASDAQ:BGLC)", "summary": "BIONEXUS GENE LAB CORP (NASDAQ:BGLC) is currently trading at $2.18, down 3.08% today, and has seen significant declines over longer periods. ChartMill gives BGLC a technical rating of 0/10 and a fundamental rating of 3/10, citing poor profitability but good financial health. The ", "url": "https://www.chartmill.com/stock/quote/BGLC/profile", "source_name": "ChartMill", "published_at": "2026-04-04T11:09:12", "published_display": "04 Apr 2026 11:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (NASDAQ: BGLC) taps new CCO to drive Fidelion VitaGuard MRD commercialization", "summary": "BioNexus Gene Lab (NASDAQ: BGLC) announced the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of its affiliate, Fidelion Diagnostics. Dr. Meyyappan will lead Fidelion's global commercial strategy and partnerships for the VitaGuard\u2122 minimal residual disease liquid ", "url": "https://www.stocktitan.net/sec-filings/BGLC/8-k-bio-nexus-gene-lab-corp-reports-material-event-b8cb3627afa4.html", "source_name": "Stock Titan", "published_at": "2026-03-17T18:39:08", "published_display": "17 Mar 2026 18:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging Earnings Estimates Signal Upside for Albemarle (ALB) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSEU0NFB2ZjBHN3pQNm1NVmxhNkt1el9jenVFMnM3eW1PYWwwTG9faUVWUzBjblI5QVNXdlR2RkpWU0k2eEFsYWZHWWNlUmpmUC1rR0JGQkVkMzlTaHIwVV9BR2M5YWdnM3d6dk5qUlFWb3BFYTFKVTY5RFZLai00ZFZQR3NiTjhZZTdZVlNHUkpvLVdqTG0zX3ZOUQ?oc=5", "source_name": "Finviz", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy, Sell or Hold Vale Stock Post Q4 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWmR1Y0NrcUFUdVdsa05zcTdSWGlnakZxRzloRDRVNXczTTFsXzVCLXgxd29UV2NnWDZJYWhwZXRGWlpGalc1NngwYndUMmFTMDBpODRZcW90T0d6WVVhYnhlN3NDam1lS21OdGYzekhMOXQ5aF9sVFdhUTVKSmc0d0dvQ2FGdFlSY09KSWZrOXl0d2gxbVpCenJvWkxjRllja0R2X3ZOM3NHOWxVank3cA?oc=5", "source_name": "TradingView", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Launches Regional Deployment of VitaGuard\u2122 MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN\u2019s Multi-Billion Dollar Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONlBZMndDX1F5blllZUxkclQ3STRFN1hPalhVQVlCamNnWExaekpIRTh4dE5fNUl1LXVsTmZJMDBmT2hsNk1kVlVEamR5V2pEeHkwX3ZjcnZ4YUx0S244djFRU1hjLVJZd0lPNVRqZ2QxSkZyMEdSVlB0aXR2b00yTkI3cFYxVWJ3QWlaZXFHX3NBVXJ1YzBpMA?oc=5", "source_name": "Market source", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is a Stock Market Rotation Underway? These Sectors Are Outpacing Tech in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeW1Db3VBaXpyc2tudmdQUk1ONC1hQ2Z6S0pvMG5Na25nX0cxWkQ2OFoxMzNheVNOTk1FQXk3amtJWl9QSVBVdjl5ZklsMWI2YzNUWGpVZEk2ODE5VTlLMEZfY2lGRGhXbE94cnZiaW9FNnhlNFdrMmZrY1BKUGN5LS1NRUdXdFBkeWN0eFJTcVlzU05pUThQdEp4YURfMjE4Zko2Y011UmJEcEU?oc=5", "source_name": "Morningstar", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "About BioNexus Gene Lab Corp.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5mWFZRTXN3MlUtODJ3X1liczlHZWRnZzB2aGxNVHhDNmNHOFZZaHJzbWMtVmVnelFBU3FjUlZtZFZoZGg3dDdMUGZtV2dINHQxUzJSc0NRQUZJUDdfc1U5LThuYmFXZw?oc=5", "source_name": "ARC Group", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPenlzbVNpei1nLU9xZldhdk5YZ3ZTZDlVWWNUYkNCYUY1Q184MlRQZ0RoalQwWVVXWVNoWVNoOHlFOXhRWmg4SjFYUkVMUUhoMmFFZmd5aURQd0ZLUW1NSWJObmJxZ1htWGdmY2VGZFZvN2xpZGJLY1AwbFc5clJya1UwX1lLNVdKcVMwd3hDTHdwUFNEVnNTZzBPSWI0d3VLTEhjZ0lySmtRaXlfQXo1bnpjQVlHUlIwb19qSVh5cnNDM2xPRlNqamhWQktlQ283cWhJOHlta1JjLXNHT0tsU3RFRUFLTlhrd1d5QTVxQmk5NjR1c1l2SGZBZjRBRWVVTkE?oc=5", "source_name": "BioSpace", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market news: Senti Biosciences surge by 428.24% while Mondee Holdings plunged by 46.49% during mid day trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxPemZGWWpFMlBOU2E0WWNpSnRCal9xaGNzU2NCcmVudlA4RXFLaU5kbnMybThiSFF4M2dtMWRvY3Z5R0NXNnNrdzl4ZzBBYjRvbWNBc25SbEVJZ1F2M0J5QlBCSmpLcTdiUUFaZUFsSjhaeHpnSGRJRExuOGo4OThMdGhoYlJQNGVwTk5fY2hyR3VvZlpZR2ZxUk92ckx6ZVVqOWI4SU95VFF5VVlPUWZSLV9fM2JGUEpqell5eVFKdkw3S2psUXFFV0lnT3ItZGpYd2V2S3g3RWxBU0tsUzZlMnlPTXpRYjR0RWhjY0UtOFZVc3pN?oc=5", "source_name": "Business Upturn", "published_at": "2024-12-02T08:00:00+00:00", "published_display": "02 Dec 2024 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFByVzROVzctaEM4SDBYUU4tb3ZfSkN3dFUwT1RuQnk4QlBHdzh2VkpnY080cDg2Z1ZnSGYtd210U24zNDZpa2VZWVFxcjBVbGZx?oc=5", "source_name": "CNN", "published_at": "2024-02-15T22:23:41+00:00", "published_display": "15 Feb 2024 22:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. (NASDAQ:BGLC) Stocks Shoot Up 234% But Its P/S Still Looks Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUnBJRkhBanM3Y2JLTzdUN0lITVZ5QlFadGtKQWNRTGdhUWVzNXdmZDFxOWZiVHNOVUotTXNhdW9MWHJkaGU2eklZMnpqSmFuYlNPWW5TdGFUSGx2MXVZYjFzUVRKZXhXWm5lM1N4YlpLajBFeUNmNXFYQW9mZWFyOW9QWjd3a3RFOUZsQUpKV0tmcjQzUHJtUWppeURfbjhUcnYwQXpReTB4OWw4V3dDTHpBRUFLNFdZWmRYVGFNY0ZnUWFGNEo3bnhlNVoyLVJyNEdBQUdB?oc=5", "source_name": "Sahm", "published_at": "2024-02-14T08:00:00+00:00", "published_display": "14 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (BGLC) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFA1TzJ4dVQ0MURMT1U1T19KNU4xZFliZGtJTWpDOTRRS2JQZ3NvTURTSEtKVERqWDMtdy1vdHBSb3Nockd5dXN1Q2xjR054UGpGcmVGc28zcGFHcENscmxqa2JPeEJfQQ?oc=5", "source_name": "MarketBeat", "published_at": "2023-08-22T18:25:37+00:00", "published_display": "22 Aug 2023 18:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy BioNexus Gene Lab Corp. (BGLC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5OeHJDVzdlcmY3SmRWQnh2UnV2SDNneHNlRG1oTjVWN2F6VHpqN2VGU0hDN2tGa2N0dDJJZ09RNU83eDF5UDkwYlFzSkwtdkhqNXR5UHFzTGFhRWZSUHdiNUdsaHpFMlJ2ZnkxdA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2023-07-23T23:21:59+00:00", "published_display": "23 Jul 2023 23:21", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC Stock Price and Chart \u2014 NASDAQ:BGLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBjQnR6REI3ckoybGJ1NDJ2bnNyU0RTWWg5cUwtb1YweUdSRFZuTVZ2M25oMXktYmtyMzNTaVRsOGFMeHlsaHpDaEVRWW5uTXhGUWZXN3BycEtuT2tv?oc=5", "source_name": "TradingView", "published_at": "2023-07-20T18:23:21+00:00", "published_display": "20 Jul 2023 18:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionexus Gene La (BGLC) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9uaU8zWnI1MmRqLVhybXR3NzJWQmdwemR1S3Q2b25xUXhmRXlvTldRdnBDQ0dpc1ZkYkVlNVhTd042ZVlqVC1RbktWSGROdw?oc=5", "source_name": "Stock Titan", "published_at": "2023-07-20T17:37:12+00:00", "published_display": "20 Jul 2023 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Brenntag stock holds steady as the chemicals distributor focuses on earnings and portfolio strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOOVhMMGVaUU1WSnBwcktjRkdVWEJOMGp2Vm9aUlFNMGlHTTlQeUk1VnIwVWo5cEJTOHZxSm5oUF9hcjc4clFYTFhyRWxLQlh3a3ZxMEtGbHRiQXFmX2FGTkhIMV9fcW5ScDN2b2s2R0p2SFRrVVFaR3ktYnAtdjFnOE13VnZiQTNEOU5xRngzSWpscmxoSy1peHpzMTVCMDFxWEJOQ3NGbGdWa0NhandNbmROWW50SVl1VDJRdmY0WkUyY2d4?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T19:07:13+00:00", "published_display": "15 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Nucor (NUE) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPWmxCZnlHNXQ3eWE1NkVVWTFMZEI4ai1oN1NQWmJoQ0VXUWtpQllBMmVNbmZ6eFl6OExTREVVM0JQejVOZ2Nqb3dDX2tEQ3AtNEE1T1IzX2VNS3RiZXRjSm1wNUxsYVBDVjZLSURiZHJITm1TWWdnQ0Zpdm8ybXVtcmxfRFdyb2c?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:40:03+00:00", "published_display": "15 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Croda stock reflects specialty chemicals strategy amid evolving global demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRnpyWDh4eXJkRDhXZ3dSSWRkNDRpeFlBZENqZllwZWZkVzVHcnAxQVFqSnZ5dTBuQzJHMXU1Y3l5OTBjY2Jfd0JNS05VVHZhYnhZUGlnNjA3SG5LeGR6eklOdFdwOHpvUTVpblItcGJfbklfRzZURTBFam44a1k5c3RZbm40LUE0OVVJbTZRR2xSMXNidTVRbmtkajlZRmRkOTdkLVZ6TlF2Szl6SjNvTWdLNENSSmE3LU5QeVZ6YlNpV1hER0k3RA?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T10:24:50+00:00", "published_display": "15 Jul 2026 10:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kemira stock reflects steady water treatment demand as specialty chemicals strategy evolves", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZjlGazNUT1JsWElvMWdxbVZ1SU81UkhtVktQWnFDTTFrSzNiMDU2OU1abl81ZkYxZ0N1OUZReTR5Y0NsR19tWHpWQVRNTDdidkNyc2pGMXRWQld0aHU5bnE0aDk2VzM2Zkw0VFFBUV9oc2YyYUdZM09KM1BBaUpab19hOXB1MkticUJFYno5dDE3R05rdmR4Nm9UbVpVSzQ2NER2Skc2eldwakxpUUpJZHFObkR5NU1PUUVCTmFEeF9ZX09lTW0wc1prankxQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T08:04:23+00:00", "published_display": "11 Jul 2026 08:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evonik stock holds steady as specialty chemicals strategy targets higher-margin growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNRXhUTWdEZHNCbjJiR0phSGswLWs0T0ZCajRmSUNZdE5Td2hjbGFHVl9HZjhBU0dvaFNyWGxGbnZteWtLN3ZQZkctU0RQLTNybTFXam5CdlB1NEh1QWRFWjJkeEFlakp5aTZqVnRYRGdiQlJFN0E3NDFFcThiTmhPbURXTmRsaF9UX2NaaFlRSkFxOERCR2ZsWHNpdGdJZmxlbXNCSlB5Y0tjT2JwMnhHRjVEekhQZmVuTVFGaEN0dnExUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T11:52:51+00:00", "published_display": "10 Jul 2026 11:52", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dow stock holds steady as chemicals demand shapes earnings outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOcGpkQk9DeEI3blpxc0RSeTh2UVhkYV8xbjYyd21IUlZDQ2ZLVW1NcW1DTk9ESXlHRHYtb2J2X29oRmdTYVROTjBXWU9QMlpSeENXT2xHMXV3S2xtRWQ1Tzd6WjBuc1FoZmR6SWRkSXpRQldIOUE2a0ZUV3oxcnkyRXR3Nmk2YWdnRG1QQWhKeFBZaUs4ZnFFM3MxNElnRmZJYmx0eGpJWGFPUnUyUFJJUWc0eXptOEQyQjBKeUlsTzZxdkE?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-10T11:09:56+00:00", "published_display": "10 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ESI stock stays supported by specialty chemicals exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRFdBa1k2YzYxY2tPMW9lQjZtSzVRUEZJdmNwVHUtM2NGdVlSQ0JPeUpCUXNfc2pINmRWMTBBYTRCZEJiZ0RJdk9RWVRvRFVQY3h6WGNqdEFfNWFsWEtMSmN5ZzBzNGhjcnVudEtuX0s2WnNNQ2M2aWx0YkNxV2NxSk56bGFVb2pEckpUMW1qVGQ3emItYTBtd3pOV0VVQTRYdDdDVGlaUFlPSHFkYUJZaHJQYzlJdVU?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T18:07:25+00:00", "published_display": "09 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADEKA stock stays supported by specialty chemicals demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQVW9MNGVDYWh4czVqV25mRjh4dDc0OTByZWdBX0NRTkpIOEJHOHcyTkw2d0dBSDd6VmM5RUdaaHVsZjZWMFJLLUMwRVZOTkdGaFFIcTB2Qk00RnhqX1NSYnVRd2lFckFEeGlTZnVKRXpUZnFDSVhhZzQxT0NXSmdUeTlhRURZZ3A3ZXRQeDJneGdBbmMtVG5HSHlRMHZ6TG5LcWhiRy14RHgzWFZOSDBwNEk5RGtvUWM?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T14:29:24+00:00", "published_display": "09 Jul 2026 14:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is LyondellBasell Industries (LYB) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRVFBOXJPUmFJN0taTHZPaWo0LUxGNjVaWlM0TzJTWkkyWm5DT09xdnk4X3lXM3pPMzViMXJ1cy1GcGFfbzNYNmxKWThwX2gtRDZqM3o4RTEyODlSeWU4MDExMWM3S0RtQUh2bmlWT01qakhodWp2X0V4bURMOUF0SUpjRmNBX3VKSVcteFdaMXRnQlRZLVR1UFRvOWM1cDdDRHhobGwwMkdOeFl4QURZ?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "The article focuses on the enterprise value to revenue forward metric for BioNexus Gene Lab Corp (NASDAQ: BGLC). It presents the stock's financial overview on TradingView, indicating that the market was closed with no trades at the time of publication. The content is primarily a ", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:39:45", "published_display": "28 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celanese sets August earnings date, analysts see cautious stock outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZVJ2MXpSM0FaLVVBTXg2c1Q3elJYdnR0UWowYVoxbERhUHZab0JmQlpiU0tZbHR0SFZiSlNvemIxcEM2VUVGVWZvNi11UHRxdzdKeHJEQ2V3WU4ydHh3a3hLWjljUHY4U29mZXYxU0FROFdpLTFMSDF1bzBQcGg5RW83bWxjRXF5dGVRWEZJcE5rRHFnbWtGZDlxQUlrZF9mOEp6RzJod1hqbFd5d2pTUFEzdkJET1hxLVRnTllHYlpKT2dFdkd3Tg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial information for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication and no trades had occurred. The data is presented within the contex", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T03:09:49", "published_display": "28 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Company Profile & Introduction", "summary": "The article provides a company profile and introduction for BioNexus Gene Lab. It offers basic information about the company.", "url": "https://www.moomoo.com/stock/BGLC-US/company?chain_id=Name1K9-3FXPhg.1l0sio0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A39,%22f%22%3A%22www.moomoo.com%2Fus%2Flearn%2Fdetail-berkshire-bites-into-domino-s-what-lies-ahead-110592-241111183%22%7D", "source_name": "Moomoo", "published_at": "2026-06-27T22:40:49", "published_display": "27 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its \"Price to book forward\" metric. It states the period value and change percentages for this financial indicator. The content is presented within the context of a TradingVie", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T21:39:27", "published_display": "27 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of BioNexus Gene Lab Corp \u2013 NASDAQ:BGLC", "summary": "This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its Enterprise Value to EBITDA forward. The data is presented within the context of a TradingView financial analysis page, detailing market information for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-BGLC/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:41:15", "published_display": "27 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Croda International outlook under scrutiny, analysts track specialty chemicals stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVjZqUzJBQjhDb1dPMlpoY0hsclY0bTlQdWhjV1pfQ2RVZDhjTzQ4U3lXNnBUUHR2ZzBYd294TDBiNV9tYzA3dngtNzQyRE52ekl1c1ZCNVlETGd6S05ycFY1Ukw5dTdTcHg2Q0YxSGpDMnFYS2s3eVhLMEZIaE1iTE1xYjMya0xzempoTFY5NGRlX3MwR0c5aDV1MlBJclRKeHdOVjhiWHVwMnBIZTlXUUpWSTkyQXd0cm84cDgwYVpmOGJn?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-27T07:04:59+00:00", "published_display": "27 Jun 2026 07:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (BGLC) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwJBVV95cUxQdS1lVFZhY0NBX1MtazlON2VaQWVhcXh4Z3B5OWxJOVdnZFo4Sk1DdmpNdU04TFJHaktHOE5XNWE0clR4RE9GMW1GdXpaNGJFaGt6b2x5UHRmV19Id0h5YzVfemxVYzA0YWMydFVnSjlZNGNWWDlCWXVlLXQ1Q1AwTEdrVTNpWFZZaFBVMjBrYl9pMzU5azhBM1ZtWEhpbThwc3VlblhCeURDS0ZfYzE1WGIxNVdYdTVfZWxfNndhcHlCWGJuU2NjUGk3TUY5VFIwM2RqTnpmbEc5eGRVaDg2WEFLQThFcVlkSFh3bE51YThfTWMzTUJJajMtdE1OS1lYQXlUQlc4d1ZjQ0J1ZV9NUHh1VGs1SmM0LU5pcDVjVk5zOGpBWXBrbTdQSFhLUEY2bXR5VmxRWmhQMnc?oc=5", "source_name": "Moomoo", "published_at": "2026-06-24T09:43:00+00:00", "published_display": "24 Jun 2026 09:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of BioNexus Gene Lab Corp (BGLC)'s dividend history and stock split events. It states that no dividends have been distributed in the past five years and lists one upcoming merger stock split event with a 10->1 ratio scheduled for April 3, 2025.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:50", "published_display": "18 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses the revenue breakdown for BioNexus Gene Lab Corp (BGLC), noting that relevant data regarding business segments and regional revenue and profit contribution have not yet been disclosed by the company. It highlights the current stock price and market capitaliz", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T08:39:50", "published_display": "18 Jun 2026 08:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of BioNexus Gene Lab Corp (BGLC), highlighting its current valuation score of 8.38 within the Biotechnology & Medical Research industry. It notes the company's P/E ratio of -1.76 and indicates that key P/B, P/S, and P/CF data have not ye", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T04:10:45", "published_display": "18 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Institutional Confidence", "summary": "This article from TradingKey provides an overview of institutional confidence in BioNexus Gene Lab Corp (BGLC), including its stock price, market cap, and various TradingKey Stock Scores. It details institutional shareholdings and recent changes in holdings by key investors. The ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:50", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for BioNexus Gene Lab Corp (BGLC), indicating that no earnings forecast score is currently available for the company. It notes that the Biotechnology & Medical Research industry average is 8.13 and states that relevant data for financial", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:05", "published_display": "18 Jun 2026 02:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus urges Malaysia-China biotech cooperation to evolve from trade to co-development and regional healthcare integration.", "summary": "BioNexus Gene Lab Corp. calls for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on co-development, clinical validation, and commercialization. CEO Sam Tan emphasized Malaysia's strategic position as an ASEAN hub to facilitate", "url": "https://pluang.com/en/news-feed/bionexus-gene-lab-corp-ajukan-kerjasama-bioteknologi-malaysia-china-lebih-dari", "source_name": "Pluang", "published_at": "2026-06-09T23:44:04", "published_display": "09 Jun 2026 23:44", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Urges Malaysia\u2013China Co-Development of Biotech Platforms After Kuala Lumpur Forum", "summary": "BioNexus Gene Lab is advocating for increased biotechnology co-development between Malaysia and China, alongside the establishment of regional precision healthcare platforms. The company highlighted its proposals at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, focu", "url": "https://www.tradingview.com/news/tradingview:57b4dadcf3049:0-bionexus-gene-lab-urges-malaysia-china-co-development-of-biotech-platforms-after-kuala-lumpur-forum/", "source_name": "TradingView", "published_at": "2026-06-05T12:39:32", "published_display": "05 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia\u2013China biotech co-development model", "summary": "BioNexus Gene Lab Corp. (Nasdaq: BGLC) is advocating for a shift in Malaysia\u2013China biotechnology collaboration from simple trade to deeper co-development, clinical validation, and regional commercialization. The company suggests Malaysia can serve as an ASEAN \"execution hub\" for ", "url": "https://www.stocktitan.net/sec-filings/BGLC/8-k-bio-nexus-gene-lab-corp-reports-material-event-32f4157ff1dd.html", "source_name": "Stock Titan", "published_at": "2026-06-05T12:39:32", "published_display": "05 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC - BioNexus Gene Lab Corp Stock Price and Quote", "summary": "This article provides a detailed stock quote and financial overview for BioNexus Gene Lab Corp (BGLC), including its recent stock performance, key financial metrics, and executive information. It also lists recent news announcements detailing the company's strategic partnerships,", "url": "https://finviz.com/stock?t=BGLC", "source_name": "Finviz", "published_at": "2026-06-02T21:40:52", "published_display": "02 Jun 2026 21:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 2.37% as Stock Tests Key Support Area - Ascending Triangle", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPZnF3d1RYQzJDRWtGSjVOQjNicXlrT0Z0empuaExpblNPcXVMNThpQVU4RGRVT0NDQ0xGUmtvX0xSekpidHpMRnhRS19qYl96RzNHRzlNQ3lFcEdpQlYyMlhheWNFX3BNWldSN284MjEwRmt6UjRvNVl6SXE0LXlZX0stazcwQlgxQ0RoalVwS1pkdnpFaHVjY1NmWUlna2ZESmpoalliWFBvekk2MmFOcjZlc3dHNEE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development", "summary": "BioNexus Gene Lab Corp. is advocating for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on joint development initiatives. The company believes this shift, involving shared research, technology transfer, and co-creation of sol", "url": "https://www.geneonline.com/bionexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-collaboration-focused-on-joint-development/", "source_name": "GeneOnline", "published_at": "2026-05-31T11:09:54", "published_display": "31 May 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia\u2013China Biotechnology Cooperation to Move Beyond Trade into Co-Development", "summary": "BioNexus Gene Lab Corp. emphasized the need for Malaysia and China to deepen their biotechnology cooperation beyond trade into co-development, clinical validation, and commercialization. Speaking at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, BioNexus CEO Sam Tan ", "url": "https://norfolkdailynews.com/online_features/press_releases/bionexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-cooperation-to-move-beyond-trade-into/article_bfee0d2e-0087-5c69-a5f2-abea6b14470c.html", "source_name": "The Norfolk Daily News", "published_at": "2026-05-29T13:10:00", "published_display": "29 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Turning Malaysia into a bridge for China\u2019s biotech ambitions", "summary": "BioNexus Gene Lab (Nasdaq: BGLC) advocated for deeper Malaysia-China biotechnology cooperation at the 2026 China\u2013Malaysia Economic Cooperation Outlook Forum, moving beyond trade to co-development. CEO Sam Tan proposed Malaysia as an ASEAN execution hub for precision diagnostics, ", "url": "https://www.stocktitan.net/news/BGLC/bio-nexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-3vcsetm0qrdk.html", "source_name": "Stock Titan", "published_at": "2026-05-29T13:08:52", "published_display": "29 May 2026 13:08", "sentiment": "positive", "sentiment_pct": 78, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. Calls for Malaysia\u2013China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxOdG1WQ05FMnltWlFfbDhGNHpuXzN0WUJaNmdNWk1rQjFWc1pvM2J0dUNmbUh5azVyUllrQkxmTHBWVzhaa3Y4UTdWV3ZqZ0cxa2pLSDdvc1hJYXJCOVBmOXRNdjdwZW1ta2xrUVh6Q005U1c1Zk5wZmdsOS1sVkxPUHV1LU9EV2VjR3NWVVpNRWhwR0FYMGRFcFRUVWFJOFdjNjVYVWEwZTZmai00Q2xqTnRBZExySkxBcUJOTmQtRHpuRFdxclN1OW1MZ19MbTVlLVAtY015bVRwQzF3QVBZa2oyOG9LVFFBSWRGTDB6WHUyemlVNUNoejhqUU04d3UzRzVKY0d3WWI0LWVpUnN2YkJkd00?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears \u2013 Key Levels to Watch - Gap and Reverse", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPdkJxNnVZdFp3ZENmY3F5VktiRXdBZXRzUEhzZlROUE5MNUV3elFWdGVfSDFfS0RtdXhqRG5DVWJPT3RFNklSNjBaTE10WkktYmFnVkJOYnZ2VnRJWFptaUFtc3JDZ1R6dUtYWG1WS0FZeFpRdWVBVXZWQzZ6Ukk5VndqYkJ0cTB2U1JPM2s3SzZEVFV1b0dQeDh6R0JPQ3N6TE0xeFNYaDNXc2NiS0lHVjhqbkZDb2kxQnZPZUdTc205TmI1MlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 3.33% as Stock Tests Key Support at $2.20 - Fibonacci Arc", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOU2JyWW5Ya29telctZEZrUnNTS2hHLUhkZXRpUHRVQmhNM0xwM05faFljWlRoSzZDWmV5MHE0eFo4Y0dYX0RPNUlFUlo4OFlkT1pmZ09EZUFVSmFyTzQxYWdNM203MGpOTkN1eF9xOS0td3B2NlVnQTVwQXlBdmpYTTZFZjhLazdxdDNiMFBOSVFaaDhjUkVGakZIQmxMUDEzVUVmY01rYzBELWhudERHQTl2RTFYQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under Scrutiny - Mid Cap Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQYXdXOHpIM2NGaUs4OEt3eXRJUWcxMTBKT2dFZVNzVEdYem1vY3drd2dJU0k2VGxXTlNseHRJZmNpbDNUZ2E1dER5T0JCVkk0RGxiR21pYTRldFF4N0RvTkFjaDBTLWI2XzdiaHk4T1VkT2xzOGhiYzFueXUzMU1Rb1QyNDkzbnhEeURoWHJmM0RVeldHZzZvOTl5MGE5U2stS04wbHV6aDZqLThIUHBXcDZ1RGJRd0VVTlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slips 3.33% as Stock Tests Key Support at $2.20 - Long Term Entry Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPOC1mYnNkSnBKQmFGQUlDVVU4RndTNHZqMlpJcFFpYmVILVZRV05uUzVHdl9aa3RUSzJIbjR1a0xocm5VeU4yTmFNYS1zNzZUV2YxTFh3anBfVmt4ZVV5ZWdCLTcxaEJlV3BTSXFFdU91WWlMd1hXaWFXTkM1R2FvSVZaY3ZOSEZaWmhYSkVCenFIQ2hKLUMzejRKb2ZrUE5IenBBYjg3eGtUT2FkaFVhNg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under Scrutiny - VWAP Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPSW0ydmdtZm9xMnBDTHhlRHpyZ0tLUXdJUGo3YmNVSm9RX2JsaURZZks5WmFyMGlGaExrTE5CREMtNEtUaW5iYy1zSGh3NmZKdkhzWjdjRlZiMGRad3pycUQwLUliaE9oYklxR21IMFN1dXNhYU51N0poNVhVUVBnTEJjN3dPdzg4OVY3NVNsUVJlN3VMSld2YUQyWjc3RUMyUk82NW1DYTIyejMtTUI5OA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key Support - OBV Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNOTlLcVJobmxEYVhUQURodXptaXhpLUdSNWFMQ09hdnB6NE5fTFZzRWxDcVU3OUI1cHQ4T0FNd0RFSXJYYWJSSG5lOWNnRi0tV0RfaENrRXZJcjZKQnp3RS1hQmI5dGtuU0c3U3VuOFRQbVFJa3Q0VXpROFlyTTFSMTZPdDhmRjlkN21sTWtLX29hZzR2ejJDbHJaUElTS29JbGR3RE95V3FnbHBuSGdtV2N3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Industrials Stocks Moving In Wednesday's After-Market Session", "summary": "This article lists 12 industrial stocks that experienced significant movement in Wednesday's after-market session, categorizing them as gainers and losers. Companies like Linkers Industries and Heico saw increases due to factors such as earnings reports, while BioNexus Gene Lab a", "url": "https://www.sahmcapital.com/news/content/12-industrials-stocks-moving-in-wednesdays-after-market-session-2026-05-28", "source_name": "Sahm", "published_at": "2026-05-27T19:40:27", "published_display": "27 May 2026 19:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) \u2014 10-Q Summary", "summary": "BioNexus Gene Lab Corp (BGLC) reported its first-quarter 2026 results, showing a significant decline in revenue to $22.84K, a 98.9% decrease year-over-year, while reducing its net loss per share to ($0.23), a 35.2% improvement. The company is actively pivoting its business strate", "url": "https://www.tradingview.com/news/tradingview:73dd3d8d0eb9e:0-bionexus-gene-lab-corp-1q-2026-revenue-22-84k-eps-0-23-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-15T21:10:00", "published_display": "15 May 2026 21:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp BGLC", "summary": "This page provides an overview of BioNexus Gene Lab Corp (BGLC) stock performance, showing a closing price of $2.015, a decrease of 2.18%. It includes current market data, a market capitalization of $4.87M, and sections for financials, discussions, and analysis. The platform also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bglc/comments", "source_name": "TradingKey", "published_at": "2026-05-12T19:09:40", "published_display": "12 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (Nasdaq:BGLC) - Stock Analysis", "summary": "BioNexus Gene Lab (Nasdaq:BGLC) is analyzed with a market cap of US$5.2m. The company's stock has shown significant declines over multiple periods, including a 99.07% drop over five years, and analysts are not currently covering it. There are substantial risks highlighted, such a", "url": "https://simplywall.st/stocks/us/capital-goods/nasdaq-bglc/bionexus-gene-lab", "source_name": "Simply Wall Street", "published_at": "2026-04-27T06:38:42", "published_display": "27 Apr 2026 06:38", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPLUlYQWNGazVwdFFaY3Z2Qmk2blZCYWtQN2c2bTZyNFhKbm0zLTJlanpnUUwxckk3Y09LOG1RN2ZwZ056emo2NUdNRGFqQWN5SS1vUnMwcFR4Q1BKVElPdm44QTNGUXpUYzhVeEhQSkhISDlKS0lBRWJMZURjRFZ5NmdtMGE2aXM1ZTJYN1djNkZiZHJrNmpjYkpTd2N4SDhOeEs4MTd1bnZHcVFEMzUzT0VBX2VfanZnRlVJVnhJVVZUY0FHZkFpbnF2VUV0ZTJwNGw2YVA3a3YzcHVHcVJuNWJOcDdZQQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61)", "summary": "BioNexus Gene Lab reported fiscal-year revenue of $7.42 million, a 21.9% decline due to lower Chemrex volume and foreign exchange. The company also posted a net loss per share of $(1.607) and an 88% increase in operating loss year-over-year. Despite the revenue decline, gross mar", "url": "https://www.tradingview.com/news/tradingview:2679d30d35f27:0-bionexus-gene-lab-10-k-revenue-7-42m-eps-1-61/", "source_name": "TradingView \u2014 Track All Markets", "published_at": "2026-04-14T21:39:50", "published_display": "14 Apr 2026 21:39", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Aris Mining Corporation (ARIS) Stock Outpacing Its Basic Materials Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmFpNU9NQ2JPcVZjV241emlTU1BXRHY5dDE4dFktLTNlaldOZnFpZ0xWNm8ySkFnbVZlaVpBRlFDQjVuWGQxc09NZ2ZQRGo5T25pWXN3UWthcVZsbHNnV21VU3V6WEM0ZWVmTE9oZW91VFFBcW5EcVFneUNyLXpCZmdDamxBQlJxeXZ2QXZ1aGg1Y2ZfSkZkVE0zUlZaYUE?oc=5", "source_name": "qz.com", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC Stock Price, Quote & Chart | BIONEXUS GENE LAB CORP (NASDAQ:BGLC)", "summary": "BIONEXUS GENE LAB CORP (NASDAQ:BGLC) is currently trading at $2.18, down 3.08% today, and has seen significant declines over longer periods. ChartMill gives BGLC a technical rating of 0/10 and a fundamental rating of 3/10, citing poor profitability but good financial health. The ", "url": "https://www.chartmill.com/stock/quote/BGLC/profile", "source_name": "ChartMill", "published_at": "2026-04-04T11:09:12", "published_display": "04 Apr 2026 11:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (NASDAQ: BGLC) taps new CCO to drive Fidelion VitaGuard MRD commercialization", "summary": "BioNexus Gene Lab (NASDAQ: BGLC) announced the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of its affiliate, Fidelion Diagnostics. Dr. Meyyappan will lead Fidelion's global commercial strategy and partnerships for the VitaGuard\u2122 minimal residual disease liquid ", "url": "https://www.stocktitan.net/sec-filings/BGLC/8-k-bio-nexus-gene-lab-corp-reports-material-event-b8cb3627afa4.html", "source_name": "Stock Titan", "published_at": "2026-03-17T18:39:08", "published_display": "17 Mar 2026 18:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging Earnings Estimates Signal Upside for Albemarle (ALB) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSEU0NFB2ZjBHN3pQNm1NVmxhNkt1el9jenVFMnM3eW1PYWwwTG9faUVWUzBjblI5QVNXdlR2RkpWU0k2eEFsYWZHWWNlUmpmUC1rR0JGQkVkMzlTaHIwVV9BR2M5YWdnM3d6dk5qUlFWb3BFYTFKVTY5RFZLai00ZFZQR3NiTjhZZTdZVlNHUkpvLVdqTG0zX3ZOUQ?oc=5", "source_name": "Finviz", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy, Sell or Hold Vale Stock Post Q4 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWmR1Y0NrcUFUdVdsa05zcTdSWGlnakZxRzloRDRVNXczTTFsXzVCLXgxd29UV2NnWDZJYWhwZXRGWlpGalc1NngwYndUMmFTMDBpODRZcW90T0d6WVVhYnhlN3NDam1lS21OdGYzekhMOXQ5aF9sVFdhUTVKSmc0d0dvQ2FGdFlSY09KSWZrOXl0d2gxbVpCenJvWkxjRllja0R2X3ZOM3NHOWxVank3cA?oc=5", "source_name": "TradingView", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Launches Regional Deployment of VitaGuard\u2122 MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN\u2019s Multi-Billion Dollar Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONlBZMndDX1F5blllZUxkclQ3STRFN1hPalhVQVlCamNnWExaekpIRTh4dE5fNUl1LXVsTmZJMDBmT2hsNk1kVlVEamR5V2pEeHkwX3ZjcnZ4YUx0S244djFRU1hjLVJZd0lPNVRqZ2QxSkZyMEdSVlB0aXR2b00yTkI3cFYxVWJ3QWlaZXFHX3NBVXJ1YzBpMA?oc=5", "source_name": "Market source", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is a Stock Market Rotation Underway? These Sectors Are Outpacing Tech in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeW1Db3VBaXpyc2tudmdQUk1ONC1hQ2Z6S0pvMG5Na25nX0cxWkQ2OFoxMzNheVNOTk1FQXk3amtJWl9QSVBVdjl5ZklsMWI2YzNUWGpVZEk2ODE5VTlLMEZfY2lGRGhXbE94cnZiaW9FNnhlNFdrMmZrY1BKUGN5LS1NRUdXdFBkeWN0eFJTcVlzU05pUThQdEp4YURfMjE4Zko2Y011UmJEcEU?oc=5", "source_name": "Morningstar", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "About BioNexus Gene Lab Corp.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5mWFZRTXN3MlUtODJ3X1liczlHZWRnZzB2aGxNVHhDNmNHOFZZaHJzbWMtVmVnelFBU3FjUlZtZFZoZGg3dDdMUGZtV2dINHQxUzJSc0NRQUZJUDdfc1U5LThuYmFXZw?oc=5", "source_name": "ARC Group", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPenlzbVNpei1nLU9xZldhdk5YZ3ZTZDlVWWNUYkNCYUY1Q184MlRQZ0RoalQwWVVXWVNoWVNoOHlFOXhRWmg4SjFYUkVMUUhoMmFFZmd5aURQd0ZLUW1NSWJObmJxZ1htWGdmY2VGZFZvN2xpZGJLY1AwbFc5clJya1UwX1lLNVdKcVMwd3hDTHdwUFNEVnNTZzBPSWI0d3VLTEhjZ0lySmtRaXlfQXo1bnpjQVlHUlIwb19qSVh5cnNDM2xPRlNqamhWQktlQ283cWhJOHlta1JjLXNHT0tsU3RFRUFLTlhrd1d5QTVxQmk5NjR1c1l2SGZBZjRBRWVVTkE?oc=5", "source_name": "BioSpace", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market news: Senti Biosciences surge by 428.24% while Mondee Holdings plunged by 46.49% during mid day trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxPemZGWWpFMlBOU2E0WWNpSnRCal9xaGNzU2NCcmVudlA4RXFLaU5kbnMybThiSFF4M2dtMWRvY3Z5R0NXNnNrdzl4ZzBBYjRvbWNBc25SbEVJZ1F2M0J5QlBCSmpLcTdiUUFaZUFsSjhaeHpnSGRJRExuOGo4OThMdGhoYlJQNGVwTk5fY2hyR3VvZlpZR2ZxUk92ckx6ZVVqOWI4SU95VFF5VVlPUWZSLV9fM2JGUEpqell5eVFKdkw3S2psUXFFV0lnT3ItZGpYd2V2S3g3RWxBU0tsUzZlMnlPTXpRYjR0RWhjY0UtOFZVc3pN?oc=5", "source_name": "Business Upturn", "published_at": "2024-12-02T08:00:00+00:00", "published_display": "02 Dec 2024 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFByVzROVzctaEM4SDBYUU4tb3ZfSkN3dFUwT1RuQnk4QlBHdzh2VkpnY080cDg2Z1ZnSGYtd210U24zNDZpa2VZWVFxcjBVbGZx?oc=5", "source_name": "CNN", "published_at": "2024-02-15T22:23:41+00:00", "published_display": "15 Feb 2024 22:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab Corp. (NASDAQ:BGLC) Stocks Shoot Up 234% But Its P/S Still Looks Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUnBJRkhBanM3Y2JLTzdUN0lITVZ5QlFadGtKQWNRTGdhUWVzNXdmZDFxOWZiVHNOVUotTXNhdW9MWHJkaGU2eklZMnpqSmFuYlNPWW5TdGFUSGx2MXVZYjFzUVRKZXhXWm5lM1N4YlpLajBFeUNmNXFYQW9mZWFyOW9QWjd3a3RFOUZsQUpKV0tmcjQzUHJtUWppeURfbjhUcnYwQXpReTB4OWw4V3dDTHpBRUFLNFdZWmRYVGFNY0ZnUWFGNEo3bnhlNVoyLVJyNEdBQUdB?oc=5", "source_name": "Sahm", "published_at": "2024-02-14T08:00:00+00:00", "published_display": "14 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioNexus Gene Lab (BGLC) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFA1TzJ4dVQ0MURMT1U1T19KNU4xZFliZGtJTWpDOTRRS2JQZ3NvTURTSEtKVERqWDMtdy1vdHBSb3Nockd5dXN1Q2xjR054UGpGcmVGc28zcGFHcENscmxqa2JPeEJfQQ?oc=5", "source_name": "MarketBeat", "published_at": "2023-08-22T18:25:37+00:00", "published_display": "22 Aug 2023 18:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy BioNexus Gene Lab Corp. (BGLC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5OeHJDVzdlcmY3SmRWQnh2UnV2SDNneHNlRG1oTjVWN2F6VHpqN2VGU0hDN2tGa2N0dDJJZ09RNU83eDF5UDkwYlFzSkwtdkhqNXR5UHFzTGFhRWZSUHdiNUdsaHpFMlJ2ZnkxdA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2023-07-23T23:21:59+00:00", "published_display": "23 Jul 2023 23:21", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BGLC Stock Price and Chart \u2014 NASDAQ:BGLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBjQnR6REI3ckoybGJ1NDJ2bnNyU0RTWWg5cUwtb1YweUdSRFZuTVZ2M25oMXktYmtyMzNTaVRsOGFMeHlsaHpDaEVRWW5uTXhGUWZXN3BycEtuT2tv?oc=5", "source_name": "TradingView", "published_at": "2023-07-20T18:23:21+00:00", "published_display": "20 Jul 2023 18:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bionexus Gene La (BGLC) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9uaU8zWnI1MmRqLVhybXR3NzJWQmdwemR1S3Q2b25xUXhmRXlvTldRdnBDQ0dpc1ZkYkVlNVhTd042ZVlqVC1RbktWSGROdw?oc=5", "source_name": "Stock Titan", "published_at": "2023-07-20T17:37:12+00:00", "published_display": "20 Jul 2023 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 59, "sentiment_summary": {"positive": 12, "negative": 9, "neutral": 38, "score": 52, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 19.95, "count": 35}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 14}, {"event": "guidance", "label": "Guidance", "weight": 2.75, "count": 5}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 1.81, "latest_week": "2026-07-10", "one_week_move": -10.8, "four_week_move": -15.4, "twelve_week_move": -17.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.34011, "market_dynamics_buy_signal": false, "relative_strength": -58.424665, "fair_value_gap": -65.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 36.4869, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.8% over one week, -15.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 9}, {"label": "TradingView", "count": 8}, {"label": "TradingKey", "count": 6}, {"label": "Stock Titan", "count": 4}, {"label": "dars.gov.et", "count": 4}, {"label": "Market source", "count": 3}, {"label": "Donan\u0131mHaber", "count": 3}, {"label": "Moomoo", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 59}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 35}, {"label": "Earnings", "count": 14}, {"label": "Guidance", "count": 5}, {"label": "Macro sensitivity", "count": 3}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "59", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.8% over one week, -15.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Brenntag stock holds steady as the chemicals distributor focuses on earnings and portfolio strategy"}], "updated_at": "2026-07-16T04:34:46.436196+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}